Abstract 4156: BI-1808 - a first in class ligand-blocking αTNFR2 antibody for cancer immunotherapy von Mårtensson, Linda, Cleary, Kirsty, Holmkvist, Petra, Kovacek, Mathilda, Svensson, Carolin, Semmrich, Monika, Blidberg, Therese, Demiri, Mimoza, Dadas, Osman, Borggren, Marie, Pitic, Vici, Lim, Sean H., Beers, Stephen A., Gertsson, Susanne, Rohrberg, Kristoffer S., Karlsson, Ingrid, McAllister, Andres, Cragg, Mark S., Frendeus, Björn, Teige, Ingrid

Volltext